Leonabio, Inc. · NASDAQ:LONA
Anders Hove reported a 6.20% stake in Leonabio, Inc. (Schedule 13G/A)
Event Jan 6, 2026 · Filed Jan 8, 2026
Anders Hove reported a 6.20% stake in Leonabio, Inc., 596,068 shares, as a passive investor on Jan 6, 2026. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 596,068
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.60% | 250,348 |
| ACORN CAPITAL ADVISORS GP, LLC | 2.60% | 250,348 |
| ACORN BIOVENTURES 2, L.P. | 3.60% | 345,720 |
| Acorn Capital Advisors GP 2, LLC | 3.60% | 345,720 |
| Anders Hove | 6.20% | 596,068 |
Source
Related
- Leonabio, Inc.
- Anders Hove
- Leonabio, Inc. shareholders
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · Anders Hove · Dec 23, 2025
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026